Industry experts provide insights on the challenges and importance of using buffers in downstream processing.
Global outbreaks energize vaccine R&D and drive production modernization.
The authors provide their perspectives on shipping validation.
Contract biopharmaceutical manufacturing has been growing steadily and is expected to reach $4.1 billion by 2019.
A federal judge entered an order of permanent injunction against Paul W. Franck, the owner and operator of several compounding pharmacies in Florida.
The agency extends the indication of the drug in combination with bendamustine.
Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.